METHODS, STATISTICAL FEATURES, AND BASE-LINE RESULTS OF A STANDARDIZED, MULTICENTERED OPHTHALMOLOGIC SURGICAL TRIAL - THE SILICONE STUDY

被引:16
作者
AZEN, SP
BOONE, DC
BARLOW, W
MCCUEN, BW
WALONKER, AF
ANDERSON, MM
LEAN, JS
MOWERY, RL
RYAN, SJ
STERN, W
机构
[1] DUKE UNIV, NEI, DURHAM, NC 27706 USA
[2] UNIV SO CALIF, DEPT OPHTHALMOL, LOS ANGELES, CA 90089 USA
[3] UNIV CALIF SAN FRANCISCO, DEPT OPHTHALMOL, SAN FRANCISCO, CA 94143 USA
[4] GRP HLTH COOPERAT PUGET SOUND, CTR HLTH STUDIES, SEATTLE, WA USA
[5] GRP HLTH COOPERAT PUGET SOUND, DEPT PREVENT MED, SEATTLE, WA USA
[6] GRP HLTH COOPERAT PUGET SOUND, DEPT OPHTHALMOL, SEATTLE, WA USA
来源
CONTROLLED CLINICAL TRIALS | 1991年 / 12卷 / 03期
关键词
CLINICAL TRIAL; SURGICAL TRIAL; OPHTHALMOLOGY; CROSSOVER DESIGN;
D O I
10.1016/0197-2456(91)90022-E
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This article describes the trial design and baseline results for the Silicone Study, a multicenter, randomized surgical trial designed to compare the effectiveness of silicone fluid versus long-acting gas in the treatment of proliferative vitreoretinopathy (PVR). Design features include (1) standardization of the surgical protocol to reduce intersurgeon variability, (2) formulation of a PVR clinical classification system relevant to modern vitreoretinal surgery, and (3) creation of a photographic protocol to document PVR pathology. Statistical issues affecting the analysis of the outcome data include (1) the addition of a second group of patients with more severely diseased eyes after the trial began, (2) the change of a different long-acting gas during the course of the trial, and (3) recurrent retinal detachments that require reoperations with the randomized treatment, and, in some instances, a crossover from the randomized to the alternate treatment. Demographic and baseline ocular characteristics are presented for the two groups under study.
引用
收藏
页码:438 / 455
页数:18
相关论文
共 44 条
  • [1] THE RESULTS OF SULFUR-HEXAFLUORIDE GAS IN VITREOUS SURGERY
    ABRAMS, GW
    SWANSON, DE
    SABATES, WI
    GOLDMAN, AI
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1982, 94 (02) : 165 - 171
  • [2] THE VALIDITY AND RELIABILITY OF PHOTOGRAPHIC DOCUMENTATION OF PROLIFERATIVE VITREORETINOPATHY
    AZEN, SP
    IRVINE, AR
    DAVIS, MD
    STERN, W
    LONN, L
    HILTON, G
    SCHWARTZ, A
    BOONE, D
    QUILLENTHOMAS, B
    LYONS, M
    LEAN, JS
    [J]. OPHTHALMOLOGY, 1989, 96 (03) : 352 - 357
  • [3] BARLOW W, IN PRESS CONTROLLED
  • [4] BLUMENKRANZ MS, 1985, ARCH OPHTHALMOL-CHIC, V104, P291
  • [5] RESULTS OF SULFUR-HEXAFLUORIDE GAS IN VITREOUS SURGERY
    BOURGEOIS, JE
    MACHEMER, R
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1983, 96 (03) : 405 - 406
  • [6] PERFLUOROPROPANE GAS IN THE MANAGEMENT OF PROLIFERATIVE VITREORETINOPATHY
    CHANG, S
    COLEMAN, DJ
    LINCOFF, H
    WILCOX, LM
    BRAUNSTEIN, RA
    MAISEL, JM
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1984, 98 (02) : 180 - 188
  • [7] CIBIS PA, 1962, ARCH OPHTHALMOL-CHIC, V68, P590
  • [8] Cicchetti DV, 1977, APPLIED PSYCHOL MEAS, V1, P195, DOI [DOI 10.1177/014662167700100206, 10.1177/014662167700100206]
  • [9] CONSTABLE IJ, 1974, INVEST OPHTH VISUAL, V13, P627
  • [10] COX MS, 1985, OPHTHALMOLOGY, V93, P646